Clinical Trial Update: Injection of 99mTc-nanocolloid and ICG to Identify, Retrieve and Qualify TDLN in Early-stage NSCLC [NA]

View source ↗

Summary

A clinical trial update describing the use of Technetium-99m nanocolloid and Indocyanine Green to identify sentinel lymph nodes in early-stage non-small cell lu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Indocyanine Green (Indocyanine Green)
• Technetium-99m nanocolloid (technetium-99m nanocolloid)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Early-stage Lung Cancer | NA | Status: COMPLETED